These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia. Nguyen VT, Amin J, Law MG, Dore GJ. J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834 [Abstract] [Full Text] [Related]
6. Trends in the incidence of hepatocellular carcinoma in boys and girls in Taiwan after large-scale hepatitis B vaccination. Lee CL, Hsieh KS, Ko YC. Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):57-9. PubMed ID: 12540504 [Abstract] [Full Text] [Related]
10. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan. Tsai MC, Kee KM, Chen YD, Lin LC, Tsai LS, Chen HH, Lu SN. J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888 [Abstract] [Full Text] [Related]
11. Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns. Verhoef C, Visser O, de Man RA, de Wilt JH, IJzermans JN, Janssen-Heijnen ML. Eur J Cancer; 2004 Jul; 40(10):1530-8. PubMed ID: 15196537 [Abstract] [Full Text] [Related]
12. Alcohol-related and hepatocellular cancer deaths by country of birth in England and Wales: analysis of mortality and census data. Bhala N, Bhopal R, Brock A, Griffiths C, Wild S. J Public Health (Oxf); 2009 Jun; 31(2):250-7. PubMed ID: 19297455 [Abstract] [Full Text] [Related]
14. Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: analysis of 11,312 patients in Taiwan. Chen CH, Su WW, Yang SS, Chang TT, Cheng KS, Lin HH, Wu SS, Lee CM, Changchien CS, Chen CJ, Sheu JC, Chen DS, Lu SN. J Gastroenterol Hepatol; 2006 Oct; 21(10):1561-6. PubMed ID: 16928217 [Abstract] [Full Text] [Related]